|
Volumn 7, Issue 6, 2002, Pages 333-337
|
Enantiomeric enrichment of (+)-(3R, 4S)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-Methylpiperidine by crystallization
|
Author keywords
Enantiomeric enrichment; Enantiomeric purity; Paroxetine; Racemic compound; Self induced non equivalence
|
Indexed keywords
4 (4 FLUOROPHENYL) 3 HYDROXYMETHYL 1 METHYLPIPERIDINE;
ACETONITRILE;
PIPERIDINE DERIVATIVE;
TOLUENE;
UNCLASSIFIED DRUG;
4-(4-FLUOROPHENYL)-3-HYDROXYMETHYL-1-METHYLPIPERIDINE;
FEMOXETINE;
PAROXETINE;
SEROTONIN UPTAKE INHIBITOR;
ARTICLE;
CHEMICAL COMPOSITION;
CHEMICAL INTERACTION;
CHEMICAL STRUCTURE;
CONTROLLED STUDY;
CRYSTALLIZATION;
DIASTEREOISOMER;
ENANTIOMER;
INFRARED SPECTROMETRY;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
PRIORITY JOURNAL;
RACEMIC MIXTURE;
STRUCTURE ANALYSIS;
CHEMISTRY;
HUMAN;
ISOLATION AND PURIFICATION;
STEREOISOMERISM;
SYNTHESIS;
CRYSTALLIZATION;
HUMANS;
MAGNETIC RESONANCE SPECTROSCOPY;
PAROXETINE;
PIPERIDINES;
SEROTONIN UPTAKE INHIBITORS;
STEREOISOMERISM;
|
EID: 0035757355
PISSN: 10242430
EISSN: None
Source Type: Journal
DOI: 10.1080/10242430215698 Document Type: Article |
Times cited : (6)
|
References (16)
|